Perfusion Imaging Score to Predict Delayed Cerebral Ischemia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University

About this trial

Aneurysmal subarachnoid hemorrhage (aSAH) is a significant public health concern, annually affecting over 30,000 Americans and ranking among the leading causes of stroke-related life-years lost in individuals aged 65 and younger. Delayed cerebral ischemia (DCI), occurring in 20% to 40% of aSAH survivors, is a major contributor to brain injury and disability. Timely recognition of DCI is crucial for improving neurological outcomes and preventing irreversible cerebral infarction. However, current methods have substantial limitations, hindering early and reliable detection. This proposal seeks to address these challenges through determining the ability of perfusion imaging to predict DCI and correlate with neurological and neuropsychological outcomes.

Eligibility criteria

Qualifiers

Age >18 years with a diagnosis of aSAH

Disqualifiers

chronic kidney disease stage IV

pregnancy

allergy to iodine that precludes CTP

subjects with significant aphasia, blindness, or other factors that limit their participation in the cognitive assessment

Trial design

Treatments tested in this trial

  • CTP scan
  • Neurological and neuropsychological testing

Treatment groups

55 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators